| Ytd | 182.32% | |
| 1y | 585.57% |
| Open | 76.97 | Prev Close | 76.99 | Low | 76.96 | High | 77.00 | Mkt Cap | 1.63B |
| Vol | 1.40M | Avg Vol | 1.51M | EPS | -4.57 | P/E | N/A | Forward P/E | -18.89 |
| Beta | 2.65 | Short Ratio | 0.82 | Inst. Own | 96.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 55.18 | 200-d Avg | 33.25 | 1yr Est | 73.00 |
Acquisition adds first-in-class anti-CD122 Antibody, FB102, to argenx's immunology pipeline August 2
Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 1
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swic
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Forte Biosciences, Inc.
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale
NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
argenx ((Euronext &, NASDAQ:ARGX), a global immunology innovation company today announced that A
August 6, 2026 – 7:45 AM ET Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--FBRX, LXFR, SMTI,
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK, July 27, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Ass
Gainers Entera Bio (NASDAQ:ENTX) stock moved upwards by 86.6% to $3.83 during Monday's regular
Forte Biosciences (NASDAQ:FBRX) shares surged about 40% to around $76 on Monday after argenx (NASDAQ
US stocks mixed in midday trading, Nasdaq falls 0.48%, Dow up 0.19%, S&P 500 down 0.23%. Consume
Global immunology pioneer Argenx SE (NASDAQ:ARGX) on Monday struck a definitive agreement to purchas
Argenx is acquiring Forte Biosciences in a $2.2 billion all-cash deal. The $77 per share buyout expa
2:50pm: Market movers Forte Biosciences (NASDAQ:FBRX) shares jumped after argenx agreed to acquire t
Dow Jones up 400 points on Monday. Baker Hughes Co (BKR) shares rise after positive earnings and tec
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Forte Biosciences, Inc.
Gainers Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 59.7% to $0.39 during Monday's
Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans
Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a discip
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s
Dow Jones index up 50 points, Equipmentshare.Com up 15.4% on revenue guidance increase and share rep
Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular
U.S. stocks higher, Dow gains over 150 points. NASDAQ up 0.84%, S&P 500 up 0.60%. Tech shares ju
U.S. stocks higher, Nasdaq up 150+ points. Aehr Test Systems shares rose 13.6%. Other big gainers in
U.S. stocks fell, Dow Jones down 100+ points. BlackBerry (NYSE:BB) reported strong Q4 results and sa
On Tuesday, 647 companies set new 52-week lows.